Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aciclovir for HSV-2 Meningitis: A Double-blind Randomised Controlled Trial (AMEN)

NCT05452928 is registered in ClinicalTrials.gov with Jacob Bodilsen as lead sponsor.

NCT NCT05452928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05452928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aciclovir for HSV-2 Meningitis: A Double-blind Randomised Controlled Trial (AMEN)
Lead sponsor
Jacob Bodilsen
Phase
Phase 4
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
June 1, 2029
Enrollment
150 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

herpes simplex 2, meningitis, viral